Sasha Latypova confirms EU regulators had major concerns over the jabs—pressure from above overruled them anyway
Who is Sasha Latypova?
Many subscribers to INSIDE PHARMA will be familiar with Sasha Latypova. For those who are new to Sasha’s work, this is her first interview, which is very, very revealing:
The first thing to note is that she has absolutely no incentive to spread ‘fake news’, as they call it. Her work is purely in the name of keeping patients safe from medical interventions that are totally novel and untested.
That made Sasha the ideal candidate to spread the expert knowledge I mentioned in a recent post:
What was the gist of Sasha’s interview?
In summary, Sasha confirmed, from the vast collection of documents provided by her industry contacts, that the early Pfizer injections manufactured and supplied were ‘experimental’.
She also explained the huge scientific, technical and logistics complications involved in the process of production, and the various risks presented. These were identified as major issues by the European Medicines Agency in the Rolling Review documentation.
However, those batches so produced were shipped to patients anyway, in spite of the major objections from Europe’s Competent Authority responsible for the licensing of medicines.
There’s more, much more of course. Be assured also, that although this is for paid subscribers only, this interview will be shared with the various lawyers and other interested parties that Hedley and Sasha have been working with over the last 12+ months to get the truth to where it needs to get.
This is the interview (note: the next insider on my list is Brook Jackson, stay tuned):